CREATD INC (CRTD) Fundamental Analysis & Valuation

NASDAQ:CRTD • US2252651078

Current stock price

0.195 USD
-0.18 (-48.11%)
At close:
0.2 USD
+0.01 (+2.56%)
After Hours:

This CRTD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CRTD Profitability Analysis

1.1 Basic Checks

  • CRTD had negative earnings in the past year.
CRTD Yearly Net Income VS EBIT VS OCF VS FCFCRTD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA -362.19%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CRTD Yearly ROA, ROE, ROICCRTD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 -2K -4K

1.3 Margins

Industry RankSector Rank
OM -593.73%
PM (TTM) -659.9%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CRTD Yearly Profit, Operating, Gross MarginsCRTD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 -5K -10K -15K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. CRTD Health Analysis

2.1 Basic Checks

  • CRTD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, CRTD has more shares outstanding
  • Compared to 1 year ago, CRTD has an improved debt to assets ratio.
CRTD Yearly Shares OutstandingCRTD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 5M 10M 15M
CRTD Yearly Total Debt VS Total AssetsCRTD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

2.2 Solvency

  • Based on the Altman-Z score of -29.40, we must say that CRTD is in the distress zone and has some risk of bankruptcy.
  • A Debt/Equity ratio of -0.01 indicates that CRTD is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Altman-Z -29.4
ROIC/WACCN/A
WACC11.29%
CRTD Yearly LT Debt VS Equity VS FCFCRTD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 5M -5M -10M -15M -20M

2.3 Liquidity

  • A Current Ratio of 0.27 indicates that CRTD may have some problems paying its short term obligations.
  • A Quick Ratio of 0.23 indicates that CRTD may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.23
CRTD Yearly Current Assets VS Current LiabilitesCRTD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. CRTD Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 55.35% over the past year.
  • CRTD shows a strong growth in Revenue. In the last year, the Revenue has grown by 141.63%.
  • CRTD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.22% yearly.
EPS 1Y (TTM)55.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.67%
Revenue 1Y (TTM)141.63%
Revenue growth 3Y277.38%
Revenue growth 5Y81.22%
Sales Q2Q%67.47%

3.2 Future

  • CRTD is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -23.02% yearly.
  • The Revenue is expected to grow by 148.15% on average over the next years. This is a very strong growth
EPS Next Y-51.33%
EPS Next 2Y-23.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year146.31%
Revenue Next 2Y148.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CRTD Yearly Revenue VS EstimatesCRTD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CRTD Yearly EPS VS EstimatesCRTD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 -0.5 -1 -1.5 -2 -2.5

More info and screens

Find the best growth stocksShow best growing peers

0

4. CRTD Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CRTD. In the last year negative earnings were reported.
  • Also next year CRTD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CRTD Price Earnings VS Forward Price EarningsCRTD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.1
CRTD Per share dataCRTD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 -2

4.3 Compensation for Growth

  • CRTD's earnings are expected to decrease with -23.02% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.02%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CRTD Dividend Analysis

5.1 Amount

  • CRTD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CRTD Fundamentals: All Metrics, Ratios and Statistics

CREATD INC

NASDAQ:CRTD (9/6/2022, 8:00:01 PM)

After market: 0.2 +0.01 (+2.56%)

0.195

-0.18 (-48.11%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)08-11
Earnings (Next)11-14
Inst Owners0.1%
Inst Owner Change0%
Ins Owners102.13%
Ins Owner Change0%
Market Cap647.39K
Revenue(TTM)5.56M
Net Income(TTM)-36.69M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA -0.1
EPS(TTM)-2.25
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.67
BVpS-0.72
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -362.19%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -593.73%
PM (TTM) -659.9%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.23
Altman-Z -29.4
F-Score4
WACC11.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)55.35%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%46.67%
EPS Next Y-51.33%
EPS Next 2Y-23.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)141.63%
Revenue growth 3Y277.38%
Revenue growth 5Y81.22%
Sales Q2Q%67.47%
Revenue Next Year146.31%
Revenue Next 2Y148.15%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CREATD INC / CRTD Fundamental Analysis FAQ

What is the fundamental rating for CRTD stock?

ChartMill assigns a fundamental rating of 2 / 10 to CRTD.


What is the valuation status of CREATD INC (CRTD) stock?

ChartMill assigns a valuation rating of 0 / 10 to CREATD INC (CRTD). This can be considered as Overvalued.


How profitable is CREATD INC (CRTD) stock?

CREATD INC (CRTD) has a profitability rating of 1 / 10.